Mels E. Hoogendoorn
Nieuwegein, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Ten-day decitabine vs "3+7" in patients with AML aged ≥60 years: long-term results of the randomized phase 3 EORTC trial AML21.
Journal: Blood neoplasia
Published: February 20, 2026
Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 31, 2025
Interim analysis of a multicenter study on patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: the RODEO study.
Journal: Haematologica
Published: June 26, 2025
The Evolution of Treatment Policies and Outcomes for Patients Aged 60 and Older with Acute Myeloid Leukemia: A Population-Based Analysis over Two Decades.
Journal: Cancers
Published: October 10, 2024
Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients.
Journal: European journal of haematology
Published: August 25, 2024
External validation of QUiPP App in three independent European cohorts of symptomatic women.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: August 22, 2024
Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome.
Journal: Annals of hematology
Published: July 23, 2024
Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry.
Journal: Annals of hematology
Published: July 10, 2024
Health care utilization up to 11 years after diagnosis among patients with a hematologic malignancy and its association with socioeconomic position.
Journal: Journal of cancer survivorship : research and practice
Published: March 08, 2024
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 02, 2024
The GLOW trial in chronic lymphocytic leukaemia.
Journal: The Lancet. Oncology
Published: December 15, 2023
Last Updated: 09/26/2026